CurexBio’s Expert CRO Services in China are redefining clinical research through robust pharmacovigilance systems and data-driven safety insights. This expert Q&A explores how advanced monitoring, AI-enabled signal detection, and real-world data integration are helping sponsors enhance patient safety, ensure regulatory compliance, and accelerate oncology drug development. Visit: https://curexbio.com/